Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis — Vassilis Golfinopoulos (2007) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
Shared by
John P A Ioannidis
Stanford University
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
Article
2007
en
Authors
+1 more
VG
Vassilis Golfinopoulos
GS
Georgia Salanti
NP
Nicholas Pavlidis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments
Maria Kyrgiou
,
Georgia Salanti
,
Nicholas Pavlidis
,
Evangelos Paraskevaidis
,
John P A Ioannidis
Article
2006
Effects of different chemotherapy regimens on survival for advanced cervical cancer: Systematic review and meta-analysis
Spyridon Tzioras
,
Nicholas Pavlidis
,
Evangelos Paraskevaidis
,
John P A Ioannidis
Article
2009
Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-analysis
Vassilis Golfinopoulos
,
George Pentheroudakis
,
Georgia Salanti
,
Andreas Nearchou
,
John P A Ioannidis
,
Nicholas Pavlidis
Article
2006
Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis
Davide Mauri
,
Nicholas Pavlidis
,
Nikolaos P. Polyzos
,
John P A Ioannidis
Article
2001
Oral contraceptives and colorectal cancer risk: a meta-analysis
Esteve Fernández
,
Carlo La Vecchia
,
Anna Balducci
,
Liliane Chatenoud
,
Silvia Franceschi
,
Eva Negri
Discussion(0)
No comments yet. Be the first to comment.